Category Archives: Health

Work on Karak Oil Refinery to be started this year: KP CM

Chief Minister Khyber Pakhtunkhwa Mahmood Khan said work on Karak Oil Refinery will be started this year.Addressing a public gathering in Karak, Peshawar-D.I.Khan Motorway has been included in China Pakistan Economic Corridor project.He hoped the motor...

PARC to introduce about 200 national brands of different food products

Pakistan Agriculture Research Council (PARC) will introduce about two hundred national brands of different food products in order to promote value addition of agriculture products.In an interview, Director General PARC Dr Azeem Khan said the initiative...

CM Punjab directs to take effective steps to check spread of dengue virus

Punjab Chief Minister Sardar Usman Buzdar has directed all concerned departments to take effective measures to check the spread of dengue virus in the province. In a statement, he said that Dengue Control Plan should be implemented

AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting

Phase Ib Study 006 long-term follow-up shows clinical activity in PD-L1 ≥25% and <25% groups in 2nd-line non-small cell lung cancer Phase I Study 10 data shows clinical activity with combination treatment in 2nd-line metastatic urothelial carcinoma CAMBRIDGE, United Kingdom,

گڈسینڈ کا وٹامن کے2 نیو یارک کے ٹائمز اسکوائر اور پیرس ففٹین ڈسٹرکٹ پہنچ گیا، چینی فہم کی مضبوطی دنیا بھر میں لے جاتا ہوا

شینچن، چین، 28 فروری 2018ء/پی آرنیوزوائر/– 2018ء کے آغاز پر گڈسینڈ فارما سائنس اینڈ ٹیکنالوجی کمپنی لمیٹڈ (“گڈسینڈ”) نے اپنے وٹامن برانڈ کے2 کی نیویارک کے ٹائمز اسکوائر پر نصب عظیم الجثہ بل بورڈز پر اور پیرس کے 15 ویں

Goodscend’s Vitamin K2 Landed in New York Times Square and Paris Fifteen District, Delivering the Strength of China Intelligence to The World

SHENZHEN, China, Feb. 28, 2018 /PRNewswire/ — At the beginning of 2018, Goodscend Pharm. Sci & Tech. Co., Ltd. (“Goodscend”) promoted its vitamin brand K2 on the large billboards overlooking New York’s Times Square and in the 15th arrondissement of

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis

Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU INDIANAPOLIS, Feb. 13, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the European Commission has

Sprint Acquires 33 Percent of TIDAL and Creates Game-Changing Partnership

TIDAL and its artists to deliver exclusive content to help Sprint acquire new customers, reward current customers Sprint will make TIDAL available to its 45 million post and prepaid customers Sprint CEO Marcelo Claure to join TIDAL Board of Directors